Ipilimumab: Additional Phase II data

Additional data from the double-blind Phase II 007 trial in 115 patients with

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE